13F Filings History of VANGUARD GROUP INC

13F snapshot Latest parsed holdings, value, and filing-period context. 2 signals
Form 13F summary
  • VANGUARD GROUP INC Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
  • Form 13F is generally due within 45 days after each calendar quarter ends.
  • VANGUARD GROUP INC reported 4329 equity holdings with a total reported market value of $6,897,676,080,636 for Q4 2025. Top reported holdings included NVIDIA CORPORATION, APPLE INC, MICROSOFT CORP, AMAZON COM INC, and BROADCOM INC.
Manager Names, identifiers, and filing context for this profile. 2 identity fields
Manager signature
Ashley Grim - Head of Global Fund Administration
Manager location
Malvern, PA

Follow Filing Activity

Follow VANGUARD GROUP INC with Pro and return when a new 13F portfolio filing changes the record on this page.

Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.

Holdings Value

Form 13F evidence

Quarterly portfolio filings

SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.

Latest quarter
Q4 2025
Latest value
$6,897,676,080,636
Quarter delta
+$719,546,506,686
Accepted
29 Jan 2026, 09:40
Rows shown
1-3 of 3
Quarter Holdings SEC-reported value Bought Sold Net Top Holdings Form Type Accepted by SEC
Q4 2025 4,329 $6,897,676,080,636 +$226,872,744,848 -$65,832,197,576 +$161,040,547,272 NVIDIA CORPORATION, APPLE INC, MICROSOFT CORP, AMAZON COM INC, BROADCOM INC 13F-HR 29 Jan 2026, 09:40
Q2 2025 4,274 $6,178,129,573,950 +$130,752,271,786 -$30,174,949,793 +$100,577,321,993 NVIDIA CORPORATION, MICROSOFT CORP, APPLE INC, AMAZON COM INC, META PLATFORMS INC 13F-HR 11 Aug 2025, 14:36
Q1 2025 4,280 $5,531,119,721,429 $0 $0 $0 APPLE INC, MICROSOFT CORP, NVIDIA CORPORATION, AMAZON COM INC, META PLATFORMS INC 13F-HR 09 May 2025, 15:29
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .